Theratechnologies Inc (THTX)
1.26
+0.06
(+5.00%)
USD |
NASDAQ |
May 09, 16:00
Theratechnologies 1 Year Total Returns (Daily): -67.86% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -67.86% |
May 08, 2024 | -69.33% |
May 07, 2024 | -69.43% |
May 06, 2024 | -69.31% |
May 03, 2024 | -65.22% |
May 02, 2024 | -63.19% |
May 01, 2024 | -63.68% |
April 30, 2024 | -64.38% |
April 29, 2024 | -62.74% |
April 26, 2024 | -66.31% |
April 25, 2024 | -63.89% |
April 24, 2024 | -64.00% |
April 23, 2024 | -64.06% |
April 22, 2024 | -65.10% |
April 19, 2024 | -63.84% |
April 18, 2024 | -66.25% |
April 17, 2024 | -65.10% |
April 16, 2024 | -66.03% |
April 15, 2024 | -65.50% |
April 12, 2024 | -54.49% |
April 11, 2024 | -53.87% |
April 10, 2024 | -55.95% |
April 09, 2024 | -52.47% |
April 08, 2024 | -55.25% |
April 05, 2024 | -53.96% |
Date | Value |
---|---|
April 04, 2024 | -55.88% |
April 03, 2024 | -53.62% |
April 02, 2024 | -50.62% |
April 01, 2024 | -51.54% |
March 28, 2024 | -48.12% |
March 27, 2024 | -56.02% |
March 26, 2024 | -57.02% |
March 25, 2024 | -59.46% |
March 22, 2024 | -62.34% |
March 21, 2024 | -64.57% |
March 20, 2024 | -64.95% |
March 19, 2024 | -62.97% |
March 18, 2024 | -62.35% |
March 15, 2024 | -59.62% |
March 14, 2024 | -66.47% |
March 13, 2024 | -58.33% |
March 12, 2024 | -63.52% |
March 11, 2024 | -62.91% |
March 08, 2024 | -66.16% |
March 07, 2024 | -65.86% |
March 06, 2024 | -64.69% |
March 05, 2024 | -61.78% |
March 04, 2024 | -59.66% |
March 01, 2024 | -60.91% |
February 29, 2024 | -61.84% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.93%
Minimum
Aug 31 2023
146.2%
Maximum
Mar 22 2021
-29.40%
Average
-44.57%
Median
Nov 03 2022
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | -4.17% |
Aurinia Pharmaceuticals Inc | -53.82% |
Edesa Biotech Inc | -33.52% |
Lexaria Bioscience Corp | 353.1% |
InMed Pharmaceuticals Inc | -78.06% |